Surveillance of Congenital Heart Defects Among Children, Adolescents, and Adults
ID: 350136Type: Posted
Overview

Buyer

Centers for Disease Control - NCBDDD (HHS-CDC-NCBDDD)

Award Range

$50K - $800K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350136
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Mar 14, 2024 12:00 AM
  4. 4
    Due May 14, 2024 12:00 AM
Description

The Centers for Disease Control - NCBDDD is seeking non-research, cooperative agreement applications for the surveillance of congenital heart defects (CHD) among children, adolescents, and adults. This project aims to describe health outcomes, including health equity, and identify opportunities to improve the health of individuals living with CHD. The surveillance activity will involve assessing survival, comorbidities, healthcare utilization, and characteristics associated with long-term outcomes among people with CHD. It will also examine state and national healthcare policies impacting people with CHD and explore the impact of COVID-19 on this population. Additionally, the project includes the development and refinement of a machine learning algorithm for the surveillance data collected. The deadline for electronically submitted applications is May 14, 2024, at 11:59 pm ET.

Point(s) of Contact
jgi7@cdc.gov
Files
Title
Posted
Appendix DD24-0051.pdf
4/10/2024
DataElements_CHDSTAR2.docx
4/10/2024
DD24-0051 NOFO_CHDSTAR2_InfoWebinar_3.18.24_NS.pdf
4/10/2024
FAQ_document.docx
4/10/2024
Similar Opportunities
Advancing Public Health Actions to Prevent and Control Chronic Disease in the U.S. Territories and Freely Associated States
Active
Centers for Disease Control - NCCDPHP
The Centers for Disease Control's National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) seeks applications for a federal grant to improve public health actions in the U.S. territories and freely associated states. The goal is to reduce disability and death rates related to chronic diseases. This cooperative agreement aims to support integrated strategies and activities to manage and prevent chronic illnesses in these regions, which face unique challenges, including limited infrastructure and diverse cultures. The focus is on preventing and reducing tobacco use, managing diabetes, and improving oral health disparities. **Required Core Component:** Applicants must propose evidence-based strategies to promote health and reduce chronic disease burden. This includes initiatives to prevent and decrease exposure to tobacco smoke and interventions to manage diabetes. **Optional Oral Health Component:** Applicants can also opt to address oral health issues with evidence-based interventions. **Eligibility:** Eligible applicants include unrestricted entities, but foreign institutions and non-domestic components of U.S. organizations are not qualified. Applicants must have the authority to submit health system and surveillance data to the CDC and access to these data. A memorandum of understanding (MOU) or memorandum of agreement (MOA) with the local Department/Ministry of Health is required. The CDC will not consider applications requesting over $1,400,000 in funding or those that do not demonstrate the ability to serve populations in the specified jurisdictions. **Funding:** The estimated total program funding is $17,450,000, with individual awards ranging from $230,000 to $1,400,000. Applicants should expect a 100% federally funded cooperative agreement, with no cost-sharing requirement. **Application Process:** Applications must be submitted electronically. The estimated synopsis post date is November 15, 2024, with a projected application deadline of January 15, 2025. Applicants should expect an award by February 27, 2025, and the projected project start date is March 29, 2025. For inquiries, contact Monique Young at 770-488-3434 or via email at islandprogdp25-0024@cdc.gov. To apply, applicants must provide the following attachments: 1. MOU/MOA with the Department/Ministry of Health, labeled correspondingly. 2. Evidence of Ability to serve the specified populations. 3. Other Attachment Forms, as required. The CDC encourages applicants to carefully review the requirements and submit complete applications. Incomplete or non-responsive applications will not be considered.
Notice of Intent to Publish a Funding Opportunity Announcement for Strategies for Preventing Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes (Collaborative UG3/UH3 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for strategies to prevent cardiovascular disease in young adults with high lifetime risk using surrogate outcomes. This funding opportunity aims to support a multisite clinical trial that will test a screening approach to identify coronary atherosclerosis and interventions to reduce its progression. The trial will require a cooperative agreement and will include a Clinical Coordinating Center (CCC) and a collaborating Data Coordinating Center (DCC) application. The CCC and DCC applications must be submitted together for consideration. The anticipated publication date for the funding opportunity is Summer 2024, with an expected application due date in Fall 2024. The estimated award date and project start date are both August 1, 2025.
Epilepsy Incidence Among Children in the United States
Active
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention - ERA is forecasting a federal grant opportunity titled "Epilepsy Incidence Among Children in the United States". This cooperative agreement aims to conduct a comprehensive study on epilepsy incidence among children in the United States. The study will estimate epilepsy incidence rates, identify risk factors associated with developing epilepsy, and examine potential disparities in incidence rates based on demographic, geographical, and social determinants of health (SDOH) factors. The target population for this study is U.S. children aged 0 - 17 years, and the study should include a nationally representative sample of age, sex, race/ethnicity, and social strata. The applicant is expected to conduct a retrospective study using public/commercial administrative and/or claims data, electronic health records, or survey data. The dataset(s) used should have sufficient sample sizes relative to risk factors, allowing incidence rates to be stratified by these factors. The estimated total program funding for this grant opportunity is $1,600,000, with an award ceiling of $500,000. The deadline for electronically submitted applications is January 23, 2025, and the estimated award date is August 25, 2025. For more information, you can visit the following links: [Link 1](https://www.nap.edu/read/13379/chapter/1) and [Link 2](https://pubmed.ncbi.nlm.nih.gov/32451250/). For any inquiries, you can contact Alison Amoroso, the Scientific Program Official, at aamoroso@cdc.gov or 470-395-2521.
Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Data Coordinating Center (Collaborative U24 Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Data Coordinating Center (Collaborative U24 Trial Required)". This grant is a cooperative agreement and falls under the category of funding activity for health. The purpose of this grant is to develop and implement a Data Coordinating Center (DCC) for a multi-site clinical trial targeting young adults without clinical atherosclerotic cardiovascular disease (ASCVD). The DCC will provide project coordination, administration, data management, and biostatistical support for the clinical trial proposed in the collaborating Clinical Coordinating Center (CCC) application. The DCC will also collaborate with the CCC on implementing the clinical trial community engagement and diversity plans, as well as reducing health inequities. The grant requires a Plan for Enhancing Diverse Perspectives (PEDP). The deadline for application submission is October 28, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-25-007.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-25-007.html).
Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY)
Active
Centers for Disease Control and Prevention - ERA
The Centers for Disease Control and Prevention - ERA is forecasting a federal grant opportunity titled "Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY)". This cooperative agreement falls under the category of Health and does not require cost sharing or matching. The objective of this project is to conduct surveillance of diabetes in youth (< 18 years) and young adults (18–44 years) across health system and/or health plan membership-based centers. The goal is to provide estimates of diabetes incidence and prevalence in the United States, focusing on diabetes type, demographic traits, health insurance status, and geographic area to identify disparities in diabetes burden. Additionally, the project aims to ascertain the prevalence of diabetes complication risk factors, acute and chronic diabetes complications, and use of diabetes medications among youth and young adults with diabetes. The project consists of two components: Component A focuses on surveillance of diabetes among youth (< 18 years) and young adults (18–44 years), while Component B serves as a Coordinating Center providing standardized approaches, analytical methods, and measures for surveillance. The Coordinating Center will also develop validation protocols, serve as a data repository, and provide statistical expertise. The estimated total program funding is $12,800,000, with an award ceiling of $700,000. It is expected that six awards will be granted. The opportunity is currently in the forecasted stage, with an archive date of February 9, 2025. For more information, contact Dr. Celeste Sanders at CSanders4@cdc.gov or 770-488-2536. The estimated synopsis post date is November 6, 2024, and the estimated synopsis close date is January 10, 2025. Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. The estimated award date and project start date are both September 30, 2025.